Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Bioadaptives (BDPT) Invested Capital (2019 - 2025)

Bioadaptives' Invested Capital history spans 7 years, with the latest figure at -$391252.0 for Q4 2025.

  • Quarterly results put Invested Capital at -$391252.0 for Q4 2025, up 4.73% from a year ago — trailing twelve months through Dec 2025 was -$391252.0 (up 4.73% YoY), and the annual figure for FY2025 was -$391252.0, up 4.73%.
  • Invested Capital for Q4 2025 was -$391252.0 at Bioadaptives, up from -$497804.0 in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of -$370662.0 in Q2 2025 to a low of -$804763.0 in Q3 2022.
  • The 5-year median for Invested Capital is -$622375.0 (2022), against an average of -$599070.0.
  • The sharpest move saw Invested Capital soared 64.37% in 2021, then plummeted 77.66% in 2024.
  • Year by year, Invested Capital stood at -$535997.0 in 2021, then tumbled by 42.66% to -$764645.0 in 2022, then increased by 12.54% to -$668759.0 in 2023, then soared by 38.59% to -$410669.0 in 2024, then increased by 4.73% to -$391252.0 in 2025.
  • According to Business Quant data, Invested Capital over the past three periods came in at -$391252.0, -$497804.0, and -$370662.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.